PRLD

Prelude Therapeutics Incorporated (PRLD)

About Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Details

Daily high

$1.07

Daily low

$1.00

Price at open

$1.03

52 Week High

$6.80

52 Week Low

$0.80

Market cap

56.1M

Dividend yield

0.00%

Volume

137,794

Avg. volume

691,840

P/E ratio

-.54

Prelude Therapeutics Incorporated News